Glucose measurement of intensive care unit patient plasma samples using a fixed-wavelength mid-infrared spectroscopy system

Journal of Diabetes Science and Technology

Volumn 6, Issue 2, 2012, Pages 294-301

  Krinsley, James ^a   Bochicchio, Kelly ^b   Calentine, Christopher ^c   Bochicchio, Grant ^b  

^a Division of Critical Care Stamford Hospital Columbia University College of Physicians and Surgeons ^*  (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c OptiScan Biomedical Inc   (United States)

Author keywords

Continuous glucose monitoring; Intensive care unit; Interference; Spectroscopy

Indexed keywords

FENTANYL; GLUCOSE; METOPROLOL; BIOLOGICAL MARKER;

ADULT; AGED; ALGORITHM; ANALYZER; ARTICLE; BLOOD SAMPLING; FEMALE; FIXED WAVELENGTH MID INFRARED SPECTROSCOPY; GLYCEMIC CONTROL; HUMAN; INFRARED SPECTROSCOPY; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; MULTIPLE ORGAN FAILURE; PREDICTION; PROSPECTIVE STUDY; SPECTROMETER; UNITED STATES; ADOLESCENT; APACHE; BLOOD; CLINICAL TRIAL; CRITICAL ILLNESS; EVALUATION; FEASIBILITY STUDY; GLUCOSE BLOOD LEVEL; METABOLISM; METHODOLOGY; MIDDLE AGED; MONITORING; MULTICENTER STUDY; PREDICTIVE VALUE; REPRODUCIBILITY; SIGNAL PROCESSING; STANDARD; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; APACHE; BALTIMORE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CONNECTICUT; CRITICAL ILLNESS; FEASIBILITY STUDIES; FEMALE; HUMANS; INTENSIVE CARE UNITS; LINEAR MODELS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SIGNAL PROCESSING, COMPUTER-ASSISTED; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; YOUNG ADULT;

EID: 84865121695     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681200600212     Document Type: Article

References (21)

1. Fahy BG, Coursin DB. Critical glucose control: the devil is in the details. Mayo Clin Proc. 2008;83(4):394-7. (Pubitemid 351536463)
2. Tang ZP, Du XG, Louie RF, Kost GJ. Drug interference on glucose measurements with six handheld glucose meters and a portable analyzer for point-of-care testing in critical care. 51st Annual AACC Conference, New Orleans, LA, July 25-29, 1999.
3. Louie RF, Tang Z, Sutton DV, Lee JH, Kost GJ. Point-of-care glucose testing: efects of critical care variables, influence of reference instruments, and a modular glucose meter design. Arch Pathol Lab Med. 2000;124(2):257-66. (Pubitemid 30090612)
4. Karon BS, Griesmann L, Scott R, Bryant SC, Dubois JA, Shirey TL, Presti S, Santrach PJ. Evaluation of the impact of hematocrit and other interference on the accuracy of hospital-based glucose meters. Diabetes Technol Ther. 2008;10(2):111-20. (Pubitemid 351230287)
5. Nerhus K, Rustad P, Sandberg S. Effect of ambient temperature on analytical performance of self-monitoring blood glucose systems. Diabetes Technol Ther. 2011;13(9):883-92.
6. Garber JR. The FDA's Center for Devices and Radiological Health's Response. June 24, 2009. www.nytimes.com/packages/pdf/health/20090717-MONITOR-1. pdf. Accessed February 1, 2012.
7. Binette TM, Cembrowski GS. Diverse influences on blood glucose measurements in the ICU setting. Chest. 2005;128(4):3084-5
8. Kanji S, Bufie J, Hutton B, Bunting PS, Singh A, McDonald K, Fergusson D, McIntyre LA, Hebert PC. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med. 2005;33(12):2778-85. (Pubitemid 41816412)
9. Aragon D. Evaluation of nursing work efort and perceptions about blood glucose testing in tight glycemic control. Am J Crit Care. 2006;15(4):370-7. (Pubitemid 44859176)
10. Juneja R, Roudebush CP, Nasraway SA, Golas AA, Jacobi J, Carroll J, Nelson D, Abad VJ, Flanders SJ. Computerized intensive insulin dosing can mitigate hypoglycemia and achieve tight glycemic control when glucose measurement is performed frequently and on time. Crit Care. 2009;13(5):R163.
11. Boyd JC, Bruns DE. Quality specifications for glucose meters: assessment by simulation modeling of errors in insulin dose. Clin Chem. 2001;47(2):209-14. (Pubitemid 32142918)
12. Krinsley JS, Meyfroidt G, van den Berghe G, Egi M, Bellomo R. The impact of premorbid diabetic status on the relationship between the three domains of glycemic control and mortality in critically ill patients. Curr Opin Clin Nutr Metab Care. 2012. Epub ahead of print.
13. Krinsley JS. Understanding glycemic control in the critically ill: 2011 update. Hosp Pract (Minneap). 2011;39(2):47-55.
14. Fahy BG, Coursin DB. An analysis: hyperglycemic intensive care patients need continuous glucose monitoring-easier said than done. J Diabetes Sci Technol. 2008;2(2):201-4.
15. Egi M, Finfer S, Bellomo R. Glycemic control in the ICU. Chest. 2011;140(1):212-20.
16. Rybka J. [Glycaemia control in critically ill patients is justified and efective]. Vnitr Lek. 2010;56(9 Suppl):977-87.
17. Heise HM, Marbach R, Koschinsky T, Gries FA. Multicomponent assay for blood substrates in human plasma by mid-infrared spectroscopy and its evaluation for clinical analysis. Appl Spectrosc. 1994;48(1): 85-95.
18. Kruse-Jarres JD, Janatsch G, Gless U, Marbach R, Heise HM. Glucose and other constituents of blood determined by ATR-FTIR-spectroscopy. Clin Chem. 1990;36(2):401-2. (Pubitemid 20083913)
19. Kim YJ, Yoon G. Prediction of glucose in whole blood by near-infrared spectroscopy: influence of wavelength region, preprocessing, and hemoglobin concentration. J Biomed Opt. 2006;11(4):041128.
20. Magarian P, Sterling B. Plasma-generating glucose monitor accuracy demonstrated in an animal model. J Diabetes Sci Technol. 2009;3(6):1411-8.
21. Jax T, Heise T, Nosek L, Gable J, Lim G, Calentine C. Automated near-continuous glucose monitoring measured in plasma using mid-infrared spectroscopy. J Diabetes Sci Technol. 2011;5(2):345-52.